✦ LIBER ✦

International Randomized Phase III Study of Elacytarabine Versus Investigator Choice in Patients With Relapsed/Refractory Acute Myeloid Leukemia

✍ Scribed by Roboz, G. J.; Rosenblat, T.; Arellano, M.; Gobbi, M.; Altman, J. K.; Montesinos, P.; O'Connell, C.; Solomon, S. R.; Pigneux, A.; Vey, N.; Hills, R.; Jacobsen, T. F.; Gianella-Borradori, A.; Foss, O.; Vetrhusand, S.; Giles, F. J.

Book ID: 124160614
Publisher: American Society of Clinical Oncology
Year: 2014
Tongue: English
Weight: 288 KB
Volume: 32
Category: Article
ISSN: 0732-183X
DOI: 10.1200/JCO.2013.52.8562

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase III Trial of a Humanized Anti-CD33

Phase III Trial of a Humanized Anti-CD33 Antibody (HuM195) in Patients with Relapsed or Refractory Acute Myeloid Leukemia

✍ Gibson, Angelia D.; Tallman, Martin S.; Jain, Vinay K. 📂 Article 📅 2002 🏛 CIG Media Group, LP. 🌐 English ⚖ 87 KB

Combination of topotecan with cytarabine

Combination of topotecan with cytarabine or etoposide in patients with refractory or relapsed acute myeloid leukemia: Results of a randomized phase I/II study

✍ Norbert Vey; Hagop Kantarjian; Miloslav Beran; Susan O'Brien; Jorge Cortes; Char 📂 Article 📅 1999 🏛 Springer US 🌐 English ⚖ 67 KB

A Phase I Study of Fludarabine, Cytarabi

A Phase I Study of Fludarabine, Cytarabine, and Oxaliplatin Therapy in Patients With Relapsed or Refractory Acute Myeloid Leukemia

✍ Tsimberidou, Apostolia Maria; Keating, Michael J.; Jabbour, Elias J.; Ravandi-Ka 📂 Article 📅 2014 🏛 Elsevier 🌐 English ⚖ 208 KB

Phase 2 randomized study of p53 antisens

Phase 2 randomized study of p53 antisense oligonucleotide (cenersen) plus idarubicin with or without cytarabine in refractory and relapsed acute myeloid leukemia

✍ Jorge Cortes; Hagop Kantarjian; Edward D. Ball; John DiPersio; Jonathan E. Kolit 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 229 KB

A phase 2 study of belinostat (PXD101) i

A phase 2 study of belinostat (PXD101) in patients with relapsed or refractory acute myeloid leukemia or patients over the age of 60 with newly diagnosed acute myeloid leukemia: a California Cancer Consortium Study

✍ Kirschbaum, Mark H.; Foon, Kenneth A.; Frankel, Paul; Ruel, Christopher; Pulone, 📂 Article 📅 2014 🏛 Informa plc 🌐 English ⚖ 117 KB

Phase II study of nilotinib in patients

Phase II study of nilotinib in patients with relapsed or refractory Philadelphia chromosome—positive acute lymphoblastic leukemia

✍ Ottmann, O G; Larson, R A; Kantarjian, H M; le Coutre, P D; Baccarani, M; Hochha 📂 Article 📅 2012 🏛 Nature Publishing Group 🌐 English ⚖ 189 KB